"The at-risk launch of Protonix generics and the loss of patent protection on Effexor XR in 2010 makes for lumpy earnings from 2008-2010," wrote Tim ...
Effexor(R) (Effexor and Effexor XR) continues to be the number one global antidepressant in sales and prescription volume and an important therapy in ...
... Risperdal and Fosamax in 2008, Prevacid and Topamax in 2009, Lipitor and Effexor XR in 2010, Plavix and Actos in 2011, Singulair and Seroquel in 2012. ...
In another patent threat, Sun Pharmaceuticals is seeking to market an alternative formulation of Wyeth's best-selling drug, the antidepressant Effexor XR. ...
... feet of manufacturing space and currently produces such products as Premarin, a menopause hormone therapy drug, and Effexor XR, an anti-depressant. ...
... and packaging facilities, currently used to manufacture products such as Premarin and Wyeth's anti-depressant drug Effexor XR (venlafaxine). ...
For instancesavings on popular prescription medications like 75MG Effexor XR yielded a savings of 24%, 40MG Lipitor 18% and 75MG Plavix 16%. ...
The most common version is an extended-release capsule, Effexor XR. Until recently, it seemed Wyeth would be the exclusive seller of extended-release ...
The most common version is an extended-release capsule, Effexor XR. ___ People's Choice Awards Being Revamped LOS ANGELES (AP) — The People's Choice Awards ...
Similarly, analysts say, Sun Pharmaceuticals may see a 15% jump in topline by selling its version of Wyeth's antidepressant medicine Effexor XR in the ...